Related Experiment Video
Updated: Jun 25, 2026
08:49
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
Published on: May 15, 2017
DAMPs ramp up drug toxicity
1Department of Medicine and Liver Center, UCSF, San Francisco, California, USA. jmaher@medsfgh.ucsf.edu
The Journal of Clinical Investigation
|February 27, 2009
Summary
Acetaminophen overdose causes liver injury through drug toxicity and immune responses. Released hepatocyte DNA acts as a danger signal, activating immune cells and cytokine production in the liver.
Area of Science:
- Hepatology
- Immunology
- Toxicology
Background:
- Acetaminophen-induced liver injury (AILI) involves drug toxicity and innate immune responses.
- Drug-induced cell death triggers inflammation in the liver.
- Understanding immune activation mechanisms in AILI is crucial for developing treatments.
Discussion:
- Dying hepatocytes release DNA, acting as a danger-associated molecular pattern (DAMP).
- Hepatocyte DNA stimulates immune responses in liver sinusoidal endothelial cells.
- This activation involves Toll-like receptor 9 (Tlr9) and the Nalp3 inflammasome.
Key Insights:
- Hepatocyte DNA is a critical initiator of innate immune activation in acetaminophen-treated mouse livers.
- Tlr9 and Nalp3 inflammasome mediate DNA-induced cytokine production by endothelial cells.
- This study elucidates a key pathway in acetaminophen hepatotoxicity.
Outlook:
- Targeting DNA-mediated immune activation could offer novel therapeutic strategies for AILI.
- Further research may explore the role of extracellular DNA in other forms of liver injury.
- Investigating DAMPs provides insights into sterile inflammation in liver diseases.
Related Concept Videos
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...